Genetic Testing Market Size & Share, by Test Type (Carrier, Predictive, Diagnostic, Parental, Nutrigenomics, Pharmacogenomics); Disease (Cancer, Alzheimer’s, Thalassemia, Cystic Fibrosis, Huntington, Duchene Muscular Dystrophy); Technology (Cytogenetic, Biochemical, Molecular); Application (Ancestry, Traits, Genetic Disease, New Baby Screening, Health); Product (Consumables, Equipment)– Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4745
  • Published Date: Mar 21, 2023
  • Report Format: PDF, PPT

Companies Dominating the Genetic Testing Landscape

top-features-companies
    • Genentech Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Sorenson Genomics
    • Abbott Molecular
    • Bayer AG
    • Biocartis
    • BioHelix
    • Quest Diagnostics
    • Exact Sciences Corporation
    • HTG Molecular Diagnostics, Inc.
    • PacBio

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Quest Diagnostics, announced the acquisition of Blueprint Genetics in an all-cash equity deal. Using proprietary algorithms and next-generation sequencing (NGS), Blueprint Genetics is a top provider of specialized genetic testing. It has extensive experience interpreting gene variants. In order to improve patient care and pharmaceutical medication research and development, Quest and Blueprint Genetics was estimated to provide access to practical insights into genetic and uncommon diseases. The deal's financial specifics weren't made public.
  • Exact Sciences Corporation declared that it had acquired PreventionGenetics, a genetic testing facility, in order to expand its portfolio of advanced cancer diagnostics and assist its entry into hereditary cancer testing (HCT). In order to speed up the availability of HCT and assisted more individuals in understanding their germline risk of developing cancer and other diseases, PreventionGenetics offers the clinical lab, experience, and fundamental technologies required.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4745
  • Published Date: Mar 21, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising prevalence of hereditary illnesses and the growing popularity of personalized medicine are the major factors driving the growth of the market.

The market size of Genetic Testing is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2023-2035.

The major players in the market are Abbott Molecular, Bayer AG, Biocartis, BioHelix, Quest Diagnostics, Exact Sciences Corporation, HTG Molecular Diagnostics, Inc., PacBio.

The cancer segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying